| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Commodore Capital LP | $61.2M | 2.7M | ▲+49% Added · +900K sh | Q1 2026 | |
| 2 | Vestal Point Capital, LP | $46.4M | 2.1M | ▼−17% Reduced · −421K sh | Q1 2026 | |
| 3 | PERCEPTIVE ADVISORS LLC | $45.2M | 2.0M | ▲+13% Added · +226K sh | Q1 2026 | |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | $27.1M | 1.2M | ▲New +1.2M sh | Q1 2026 | |
| 5 | FRANKLIN RESOURCES INC | $24.8M | 1.1M | ▼−1.6% Reduced · −18K sh | Q1 2026 | |
| 6 | Vivo Capital, LLC | $23.3M | 1.0M | —Held | Q1 2026 | |
| 7 | ARMISTICE CAPITAL, LLC | $20.5M | 912K | ▼−41% Reduced · −624K sh | Q1 2026 | |
| 8 | MILLENNIUM MANAGEMENT LLC | $18.5M | 822K | ▲+30% Added · +192K sh | Q1 2026 | |
| 9 | BlackRock, Inc. | $15.0M | 666K | ▲+9.6% Added · +58K sh | Q1 2026 | |
| 10 | Ikarian Capital, LLC | $11.6M | 515K | —Held | Q1 2026 | |
| 11 | Point72 Asset Management, L.P. | $11.3M | 503K | ▼−69% Reduced · −1.1M sh | Q1 2026 | |
| 12 | Venrock Adviser, LLC | $11.2M | 500K | ▲New +500K sh | Q1 2026 | |
| 13 | Integral Health Asset Management, LLC | $11.2M | 500K | ▲+33% Added · +125K sh | Q1 2026 | |
| 14 | Affinity Asset Advisors, LLC | $11.2M | 500K | ▲New +500K sh | Q1 2026 | |
| 15 | NORTHERN TRUST CORP | $10.6M | 473K | ▼−0.2% Reduced · −970 sh | Q1 2026 | |
| 16 | JENNISON ASSOCIATES LLC | $8.7M | 386K | ▲New +386K sh | Q1 2026 | |
| 17 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $8.7M | 385K | ▲New +385K sh | Q1 2026 | |
| 18 | PRICE T ROWE ASSOCIATES INC /MD/ | $8.3M | 371K | ▲12× Added · +341K sh | Q1 2026 | |
| 19 | GEODE CAPITAL MANAGEMENT, LLC | $6.6M | 293K | ▲+1.9% Added · +5K sh | Q1 2026 | |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.4M | 238K | ▲+102% Added · +120K sh | Q1 2026 | |
| 21 | ALKEON CAPITAL MANAGEMENT LLC | $5.1M | 227K | ▼−52% Reduced · −250K sh | Q1 2026 | |
| 22 | TWO SIGMA INVESTMENTS, LP | $4.9M | 216K | ▲+54% Added · +76K sh | Q1 2026 | |
| 23 | Qube Research & Technologies Ltd | $4.7M | 209K | ▲+86% Added · +96K sh | Q1 2026 | |
| 24 | STATE STREET CORP | $4.5M | 200K | ▲+53% Added · +69K sh | Q1 2026 | |
| 25 | MARSHALL WACE, LLP | $4.0M | 176K | ▼−8.7% Reduced · −17K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 23 funds | $2.0B |
| BOSTON SCIENTIFIC CORPBSX | 22 funds | $631.0M |
| AMAZON.COM INCAMZN | 21 funds | $5.6B |
| ALPHABET INC-CL AGOOGL | 21 funds | $3.6B |
| INTUITIVE SURGICAL INCISRG | 21 funds | $919.8M |
| UNITEDHEALTH GROUP INCUNH | 21 funds | $533.2M |
| MICROSOFT CORPMSFT | 20 funds | $4.7B |
| META PLATFORMS INC-CLASS AMETA | 20 funds | $3.5B |
| BROADCOM INCAVGO | 20 funds | $3.0B |
| MASTERCARD INC - AMA | 20 funds | $1.6B |
| ORACLE CORPORCL | 20 funds | $1.3B |
| REGENERON PHARMACEUTICALSREGN | 20 funds | $275.9M |
Ranked by how many of ANRO's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 10, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy (P) | 3K | $39K |
| Jul 9, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy (P) | 11K | $134K |
| Jul 9, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy (P) | 1K | $18K |
| Mar 28, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy (P) | 2K | $25K |
| Mar 28, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy (P) | 5K | $75K |
| Feb 6, 2024 | Alpha Wave Global, LP | 10% Owner | Buy (P) | 600K | $9.6M |
| Feb 6, 2024 | Etkin Amit | PRESIDENT AND CEO, Director | Buy (P) | 3K | $50K |
| Feb 6, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy (P) | 17K | $272K |
| Feb 6, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy (P) | 2K | $25K |
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ANRO/capital-change-brief"
Use Arkolith's capital_change_brief for ANRO. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ANRO. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.